News Search Results
Jun 03, 2026, 00:01 ET NATIONAL MS SOCIETY, COMMUNITY PARTNERS SHOW EARLY IMPACT IN CLOSING MULTIPLE SCLEROSIS CARE GAPS IN SOUTH CAROLINA
1-800-344-4867.About Genentech Founded 50 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions.
More news about: National Multiple Sclerosis Society
Jun 02, 2026, 18:11 ET Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
June 2, 2026 /PRNewswire/ --Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Sana Biotechnology, Inc. (NASDAQ: SANA) breached their fiduciary duties to shareholders.
More news about: Halper Sadeh LLP
Jun 02, 2026, 15:44 ET First Foundation Labs, Founded by Luma Group, Collaborates with Microsoft to Bring AI-Powered Clinical and Translational Reasoning to Microsoft Discovery
complex scientific and strategic decisionsAbout Luma GroupLuma Group is a New York–based multistage investment firm focused on biotechnology. The firm combines scientific expertise with computational insight to inform its investment strategy and support the growth of innovative life sciences
More news about: Luma Group
Jun 02, 2026, 15:44 ET SLP Shareholder Alert: Robbins LLP Reminds Simulation Plus, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders
directors violated securities laws and breached fiduciary duties to shareholders. Simulation Plus is a software company serving the pharmaceutical, biotechnology, and chemical industries.
More news about: Robbins LLP
Jun 02, 2026, 12:00 ET Rise Therapeutics Completes Enrollment in Four-Week Dose Expansion Cohort for the R-2487 Rheumatoid Arthritis Clinical Trial
ROCKVILLE, MD, June 2, 2026 /PRNewswire/ -- Rise Therapeutics, a clinical-stage biotechnology company advancing novel oral immunotherapies for autoimmune diseases, today announced the completion of full enrollment in the 4-week dose expansion
More news about: Rise Therapeutics
Jun 02, 2026, 11:32 ET MT Group Surpasses 5,000 Customized Biospecimen Collections, Reinforcing Its Position as a Leading Specialty CRO for Prospective Human Tissue and Blood Procurement
-- MT Group, a specialty biospecimen contract research organization (CRO) supplying clinically annotated human biospecimens to pharmaceutical, biotechnology, and in vitro diagnostics (IVD) companies worldwide, today announced that it has surpassed 5,000 customized biospecimen collections completed for
More news about: MT Group
Jun 02, 2026, 09:30 ET Lilly to spotlight growing hematology portfolio at 2026 European Hematology Association (EHA) Annual Meeting
pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Jun 02, 2026, 08:01 ET Stevenson Search Partners and HAVEN Unite to Launch New Human Capital Platform: Tidemark Talent Solutions
Stevenson Search Partners is a trusted Executive Search and On-Demand Talent Solutions advisor serving the global biotechnology, pharmaceutical, medical technology, health technology and CRO/CDMO sectors. With offices in the U.S. and U.K., Stevenson specializes in identifying
More news about: Tidemark Talent Solutions
Jun 02, 2026, 08:00 ET Origin Agritech Co-Authors Plant Biotechnology Journal Study That Breaks the Long-Standing Trade-Off Between Early-Maturing and High-Yield Corn
Beijing Origin Agriculture Co., Ltd. — the Company's primary R&D and operating entity — are co-authors of a landmark study published in Plant Biotechnology Journal that solves one of the most persistent problems in corn breeding: how to develop corn that flowers and matures earlier without sacrificing
More news about: Origin Agritech Limited
Jun 02, 2026, 07:00 ET Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica
Lishan Biotech, BMC128 is being further developed under the designation LS-LBP-002.About Lishan Biotech:Lishan Biotech is a biotechnology company focused on the development of live biotherapeutic products (LBPs). We aim to address the substantial unmet clinical needs for complex diseases
More news about: Evogene
Jun 02, 2026, 00:54 ET High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease
Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for severe diseases, announced that the first sickle cell disease (SCD) patient being
More news about: CorrectSequence Therapeutics
Jun 02, 2026, 00:50 ET High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease
Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for severe diseases, announced that the first sickle cell disease (SCD) patient being
More news about: CorrectSequence Therapeutics
Jun 02, 2026, 00:03 ET Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update
infrastructure, pharmacy fulfillment, and telehealth capabilities.Insu Therapeutics UpdateInsu Therapeutics is a clinical-stage biotechnology company developing a patented buccal delivery platform for peptide-based therapeutics.The Company's research initially focused on evaluating
More news about: Victory Square Technologies Inc
Jun 01, 2026, 18:16 ET /C O R R E C T I O N -- Ranok Therapeutics/
WALTHAM, Mass. and HANGZHOU, China, June 1, 2026 /PRNewswire/ -- Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced positive interim Phase 1 clinical data for RNK08954, an investigational oral, selective
More news about: Ranok Therapeutics
Jun 01, 2026, 16:00 ET EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
best of biology and technology, Amgen reaches millions of patients with its medicines.More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic
More news about: Amgen
Jun 01, 2026, 12:37 ET Rubin Rudman's John McGivney Named a MLW 2026 Top 20 Managing Partner for Third Consecutive Year
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; hospitality companies; regulated industries, public entities and municipalities; insurance companies
More news about: Rubin Rudman
Jun 01, 2026, 12:00 ET Eclipsebio Expands eCOMPASS™ Platform with eSENSE Break™ to Map RNA Fragmentation at Nucleotide Resolution
[email protected] EclipsebioEclipsebio is a private biotechnology company headquartered in San Diego that combines AI-powered sequence design, rapid prototyping, and sequencing-based analytics to support RNA drug
More news about: Eclipsebio
Jun 01, 2026, 10:18 ET Rocket One Appoints Dr. Supriyo Bandyopadhyay as Lead Technical Advisor of AI Nanomagnetic Technology
defense and space systems. The Company is also positioned to pursue opportunities in nano-launch systems and nanosatellite deployment. The Company's biotechnology pipeline, including, but not limited to, HT-001, HT-KIT, HT-ALZ, and its GDNF-based metabolic program, will continue to be advanced under a wholly
More news about: Rocket One Inc.
Jun 01, 2026, 10:04 ET Made Scientific Selected as Manufacturer for Columbia University's Autologous and Allogeneic NOVAKnee Program - a First-in-Class Living Biologic Total Knee Replacement
deliver reliable and scalable solutions, supported by their long-term strategic backer, GC Corporation, a global leader in the pharmaceutical and biotechnology sectors. For more information, visit
More news about: Made Scientific, Inc.
Jun 01, 2026, 10:03 ET Connect Life Sciences Appoints Megan Driscoll as Executive Chairman of the Board
Directors. CLS, a portfolio company of Argosy Healthcare Partners (AHP), is a life sciences recruitment solutions company that serves pharmaceutical, biotechnology, and medical device customers.
More news about: Argosy Healthcare Partners
Jun 01, 2026, 09:00 ET Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
Calif., June 1, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the Canadian Intellectual Property Office (CIPO) has issued a Notice
More news about: Anixa Biosciences, Inc.
Jun 01, 2026, 08:35 ET YCODE, The Award-Winning Skincare Brand Engineered Specifically for Male Skin Biology, Officially Expands Across the US Market With Nordstrom, Via Notable Partnerships Across E-Commerce and Retail Including Uncrate, C.O. Bigelow, Formula Fig and the Sunset Marquis Hotel
formulations designed to deliver fast, visible results.Built around its proprietary From Sea to Cell™ philosophy, YCODE harnesses marine biotechnology and adaptive microalgae-derived actives to support hydration, skin resilience, inflammation control and environmental protection through lightweight,
More news about: YCODE
Jun 01, 2026, 08:30 ET EIT Pharma Highlights New Lonafarnib Analyses at EASL Congress 2026
team at EIT to advance this potential breakthrough therapy and Interferon Lambda."EIT Pharma was established by experienced clinical and biotechnology leaders to identify and advance overlooked or underdeveloped assets in areas of high unmet medical need. Under Dr. Kawas's leadership, the company
More news about: EIT Pharma
Jun 01, 2026, 08:00 ET SystImmune Reports Phase 1 Data for BL-M14D1 Demonstrating Promising Activity in Small-Cell Lung Cancer at ASCO
REDMOND, Wash., June 1, 2026 /PRNewswire/ -- SystImmune, Inc., a clinical-stage biotechnology company, today announced the oral presentation of Phase 1 data for BL-M14D1 in patients with small-cell lung cancer (SCLC), neuroendocrine carcinoma
More news about: SystImmune, Inc.
Jun 01, 2026, 08:00 ET Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis
full Prescribing Information for ZAYNICH™.About WockhardtWockhardt is a global pharmaceutical and biotechnology company focused on developing innovative anti-infective solutions. With a legacy of scientific excellence and a mission to combat antimicrobial
More news about: Wockhardt